Researchers at the MPI of Biochemistry and TUM have examined the cerebrospinal fluid of 5,000 patients with neurological ...

Researchers at the MPI of Biochemistry and TUM have examined the cerebrospinal fluid of 5,000 patients with neurological diseases and discovered new ...

“Latent herpes viruses have the potential to reactivate in people living with HIV which can lead to neuroinflammation and impact long-term brain health,” said Shirin Mazumder, MD, infectious diseases ...

At age 66, Richard "Dick" Nash first suspected something might be wrong when he participated in a Dallas walk for juvenile ...

A new AI-powered cerebrospinal fluid liquid biopsy accurately classifies brain tumours using tiny DNA fragments. Learn more.

NT Reporter Panaji Nearly 9 per cent of people above 65 years in Goa are affected by Alzheimer’s disease, compared to 6 per cent nationally, experts said, pointing to a higher incidence in the ...

Total revenue of $68.7 million in 4Q25 and $172.4 million in FY2025 – – Revuforj® (revumenib) net revenue of $44.2 million in 4Q25, a 38% ...

Introduction Burnout among healthcare professionals remains a critical public health issue linked to impaired cognition, emotional exhaustion and diminished clinical performance. Structured breathing ...

New neuropsychological tests may improve Alzheimer’s disease diagnosis and clinical research participation, according to Rutgers Health-led study.

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said new biomarker data from an expanded-access program showed its experimental ...

The AACR 2026 conference will be held from April 17-22, 2026. The AACR plans to publish the abstract titles on March 17, 2026 at 4:30 pm EST, the abstracts on April 17, 2026 at 3:00 pm EST, and the ...

Regulatory officials have granted Molbreevi priority review and assigned a goal date of Aug. 22, 2026. If approved, Molbreevi will be priced between $400,000 and $500,000 per year.